CA2371551A1 - Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives - Google Patents

Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives Download PDF

Info

Publication number
CA2371551A1
CA2371551A1 CA002371551A CA2371551A CA2371551A1 CA 2371551 A1 CA2371551 A1 CA 2371551A1 CA 002371551 A CA002371551 A CA 002371551A CA 2371551 A CA2371551 A CA 2371551A CA 2371551 A1 CA2371551 A1 CA 2371551A1
Authority
CA
Canada
Prior art keywords
apc
apocodeine
derivatives
adhesive
male
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002371551A
Other languages
English (en)
Inventor
Mario Baraldi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Publication of CA2371551A1 publication Critical patent/CA2371551A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne trois compositions pharmaceutiques: timbres transdermiques à libération prolongée; pastilles à mâcher/sublinguales; aérosols à base d'apocodéine (APC) ou ses dérivés, pour le traitement de l'impuissance masculine et pour la stimulation de la libido chez les hommes et chez les femmes.
CA002371551A 1999-05-13 2000-05-12 Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives Abandoned CA2371551A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE990389 1999-05-13
IE990389 1999-05-13
PCT/IE2000/000065 WO2000069416A1 (fr) 1999-05-13 2000-05-12 Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives

Publications (1)

Publication Number Publication Date
CA2371551A1 true CA2371551A1 (fr) 2000-11-23

Family

ID=11042062

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002371551A Abandoned CA2371551A1 (fr) 1999-05-13 2000-05-12 Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives

Country Status (7)

Country Link
EP (1) EP1175206A1 (fr)
JP (1) JP2002544221A (fr)
AU (1) AU4427000A (fr)
CA (1) CA2371551A1 (fr)
MX (1) MXPA01011480A (fr)
NO (1) NO20015519L (fr)
WO (1) WO2000069416A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001076602A1 (fr) * 2000-04-07 2001-10-18 Tap Pharmaceutical Products Inc. Derives d'apomorphine et leurs procedes d'utilisation
SE0002934D0 (sv) * 2000-08-17 2000-08-17 Axon Biochemicals Bv New aporphine esters and in their use in therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
FI873428A (fi) * 1986-08-18 1988-02-19 Houston Biotechnology Oftalmologiska kompositioner foer behandling av nervdegenerationer.
DE69709646T2 (de) * 1996-03-12 2002-08-14 Alza Corp., Palo Alto Zusammensetzung und dosisform mit einem opioid-antagonisten

Also Published As

Publication number Publication date
NO20015519D0 (no) 2001-11-12
WO2000069416A1 (fr) 2000-11-23
EP1175206A1 (fr) 2002-01-30
AU4427000A (en) 2000-12-05
MXPA01011480A (es) 2002-06-04
JP2002544221A (ja) 2002-12-24
NO20015519L (no) 2002-01-11

Similar Documents

Publication Publication Date Title
FI115034B (fi) Menetelmä uudelleenkiteytymättömän estradiolia sisältävän laastarin valmistamiseksi
FI100693B (fi) Menetelmä vaikuttavana aineena tulobuterolia sisältävän, ihon läpi vai kuttavan terapeuttisen järjestelmän valmistamiseksi
US20040202705A1 (en) Transdermal administration of huperzine
WO2008021113A2 (fr) Méthodes transdermiques et systèmes pour traiter la maladie d'alzheimer
WO2007120868A2 (fr) Amélioration de la biodisponibilité d'un médicament lipophile à l'aide d'un système de solvants
US20120309823A1 (en) Percutaneous absorption preparations
JP2540019B2 (ja) 医薬組成物
US20120077836A1 (en) Methods of administering (4ar,10ar)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof
EP2650019B1 (fr) Timbre transdermique contenant un antidépresseur noradrénergique et sérotoninergique spécifique
AU764025B2 (en) Transdermal patch and topical compositions comprising propylnorapomorphine
US20080176913A1 (en) Transdermal compositions of pramipexole having enhanced permeation properties
NO320050B1 (no) Transmukosale formuleringer av levosimendan og anvendelse derav til fremstilling av faramasoytisk preparat.
CA2371551A1 (fr) Compositions pharmaceutiques contenant de l'apocodeine et/ou ses derives
CN115475152A (zh) 氟比洛芬的外用制剂及其制备方法
CN112107561B (zh) 含有壳聚糖的药物制剂、药物透皮贴剂及其制备方法
JP6459148B2 (ja) 経皮吸収型製剤
Walters et al. Dermal and Transdermal Drug Delivery Systems: An Overview and Recent Advancements
CN112057436A (zh) 含有脂质的药物制剂、药物透皮贴剂及其制备方法
JP3841628B2 (ja) 経皮吸収剤
WO2017057541A1 (fr) Préparation d'absorption transdermique
JP2008231081A (ja) ケトプロフェン含有外用剤
Walters et al. 1 Dermal Drug Delivery and Transdermal Systems
MXPA01000527A (en) Transdermal patch and topical compositions comprising propylnorapomorphine
JP2017007994A (ja) 経皮吸収型製剤
AU2013206198A1 (en) Methods of administering (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
FZDE Dead